C.PasolliH
Patients must be at least 18 years old and meet one of the following clinical requirements when GLP-1 therapy begins: A body mass index, or BMI, of 35 or higher A BMI between 30 and 34.99 with at least one qualifying health condition A BMI between 27 and 29.99 with at least one qualifying higher-risk health condition For someone with a BMI between 30 and 34.99, qualifying conditions may include heart failure with preserved ejection fraction, uncontrolled high blood pressure, stage 3a or higher chronic kidney disease, prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease
The body no longer has to wait for one process to complete before another can begin effectively
It also helps with heart, blood sugar, and dementia issues
Recent advances in oral peptide or protein-based drug delivery systems
If you are using a dosing chart to track your protocol, add the injection site notation to the same record for easy reference